REPT BATTERO (00666) announces expected net profit for 2025 to be approximately 6.3 billion to 7.3 billion yuan, turning from a loss to a profit compared to the previous year.
RayPulan Jun (00666) announced that it is expected to achieve a net profit of approximately RMB 6.3 billion to approximately RMB 7.3 billion for the year ending December 31, 2025 (this reporting period), compared to a net loss of approximately RMB 13.53 billion for the year ending December 31, 2024, turning the loss into a profit.
REPT BATTERO (00666) announced that it expects to record a net profit of approximately RMB 6.3 billion to approximately RMB 7.3 billion for the fiscal year ending December 31, 2025 (current reporting period), compared to a net loss of approximately RMB 13.53 billion for the fiscal year ending December 31, 2024, achieving a turnaround from loss to profit.
The announcement stated that the turnaround to profit was mainly due to the following factors: continuous increase in sales volume of power and energy storage battery products, driving continuous revenue growth; and improvement in production capacity utilization and cost reduction measures leading to a significant increase in gross profit.
Related Articles

TRUE PARTNER (08657): Jialin Capital appointed as independent financial advisor, trading to resume on February 4th.

Shenzhen Stock Exchange: Nationz Technologies (02768) will be included in the list of stocks eligible for trading under the Shenzhen-Hong Kong Stock Connect.

Tianqi Lithium Corporation (09696) plans to sell no more than 1.25% of its equity in SQM.
TRUE PARTNER (08657): Jialin Capital appointed as independent financial advisor, trading to resume on February 4th.

Shenzhen Stock Exchange: Nationz Technologies (02768) will be included in the list of stocks eligible for trading under the Shenzhen-Hong Kong Stock Connect.

Tianqi Lithium Corporation (09696) plans to sell no more than 1.25% of its equity in SQM.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


